RegenLab® is recognized as a certified global leader in medical biotechnologies, specializing in cellular therapies. In the United States, RegenLab® USA provides expertly designed Class II medical devices for the preparation of platelet rich plasma from the patient's own blood. Regen® A-PRP® was developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments provided worldwide using RegenLab® products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.

Platelets are key factors in hard and soft tissue repair mechanisms. They provide essential growth factors such as FGF, PDGF, TGF-β, EGF, VEGF, and IGF which are involved in stem cell migration, differentiation, and proliferation. By using the patient’s own blood to prepare the platelet concentrate, the RegenKit® technology vastly reduces the risk of an allergic or adverse reaction.